4.4 Article

Ixazomib enhances parathyroid hormone-induced β-catenin/T-cell factor signaling by dissociating β-catenin from the parathyroid hormone receptor

Journal

MOLECULAR BIOLOGY OF THE CELL
Volume 28, Issue 13, Pages 1792-1803

Publisher

AMER SOC CELL BIOLOGY
DOI: 10.1091/mbc.E17-02-0096

Keywords

-

Categories

Funding

  1. National Institutes of Health [AR062705, AR063289]
  2. Department of Defense [PR152096]

Ask authors/readers for more resources

The anabolic action of PTH in bone is mostly mediated by cAMP/PKA and Wnt-independent activation of beta-catenin/T-cell factor (TCF) signaling. beta-Catenin switches the PTH receptor (PTHR) signaling from cAMP/PKA to PLC/PKC activation by binding to the PTHR. Ixazomib (Izb) was recently approved as the first orally administered proteasome inhibitor for the treatment of multiple myeloma; it acts in part by inhibition of pathological bone destruction. Proteasome inhibitors were reported to stabilize beta-catenin by the ubiquitin-proteasome pathway. However, how Izb affects PTHR activation to regulate beta-catenin/TCF signaling is poorly understood. In the present study, using CRISPR/Cas9 genome-editing technology, we show that Izb reverses beta-catenin-mediated PTHR signaling switch and enhances PTH-induced cAMP generation and cAMP response element-luciferase activity in osteoblasts. Izb increases active forms of beta-catenin and promotes beta-catenin translocation, thereby dissociating beta-catenin from the PTHR at the plasma membrane. Furthermore, Izb facilitates PTH-stimulated GSK3 beta phosphorylation and beta-catenin phosphorylation. Thus Izb enhances PTH stimulation of beta-catenin/TCF signaling via cAMP-dependent activation, and this effect is due to its separating beta-catenin from the PTHR. These findings provide evidence that Izb may be used to improve the therapeutic efficacy of PTH for the treatment of osteoporosis and other resorptive bone diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available